# source-check — claim cc8245cebc397f1c8ff9fc22cc4d1dfb54038f2e61bf471cc918b2b6dc5ed304

Claim: Abstract extract PMID 42778319 ("[Study on the relationship between ultrasound-based response evaluation and pathological outcomes in neoadjuvant therapy for HER2-positive breast cancer]."):  Key fragments: and those with SD accompanied by tumor shrinkage (all P>0.05). Conclusions: During neoadjuvant therapy for HER2-positive breast cancer, a trea Abstract-only SHA-256 TITLE+PMID+ABSTRACT=c187b1d4c8de3322bce41c346ad1edfd582a4b2f5ec19188946e6ccaf1161fb1. Not treatment advice.
Source: PMID 42778319 (https://pubmed.ncbi.nlm.nih.gov/42778319/)
Checked: 2026-09-25T11:11:40.781Z

## Method
1. Fetched abstract via NCBI efetch.
2. Deterministic numeric grounding: missing tokens: none.
3. Semantic check (qwen3:8b, temp 0): supports — The source text supports the claim. The claim states that 'those with SD accompanied by tumor shrinkage (all P>0.05)' and that 'ultrasound assessment has limited predictive value for pCR.' The source text explicitly mentions: 'The pCR rate did not differ significantly between patients with SD accompanied by tumor enlargement and those with SD accompanied by tumor shrinkage (all P>0.05).' Additionally, it concludes that 'ultrasound assessment has limited predictive value for pCR,' which aligns with the claim.

## Result
supports (confidence 7500 bps)

Limitations: abstract-level check only; full text not reviewed.
Source sha256: e10719ea262d36bd7e3460e193be737c9653d9e33893ec4495e5ed2872b3b9e9